ZymoGenetics, Inc. To Review Development Programs At Analyst & Investor Briefing

SEATTLE--(BUSINESS WIRE)--ZymoGenetics, Inc. (Nasdaq:ZGEN), announced today that company executives will review highlights from development programs at an analyst and investor meeting to be held on Thursday, December 14, at 10:00 a.m. Eastern Time at the Four Seasons Hotel’s Cosmopolitan Room in New York City. To attend the meeting, RSVP to media@zgi.com or call 206-442-6592.
MORE ON THIS TOPIC